ArticleCancer biomarkers : section A of Disease markers2025
PDCD2L overexpression represents an unfavorable prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
Ding-Ping Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.